Why 'organoid intelligence' is causing a stir among scientists

Brain organoid pioneers fear that inflated claims about biocomputing could backfire.

November 17, 2025 Check out STAT+

Sponsored By

Business Wire via AP Brain organoid pioneers fear inflated claims about biocomputing could backfire Scientists at a brain organoid meeting said terms like "organoid intelligence" and other claims by biocomputing firms could cause a backlash By Megan Molteni STAT+ | Johnson & Johnson acquires Halda Therapeutics for $3 billion, a big win for a buzzy new technology The deal is the first major buyout for a startup built around so-called PROTACs, a field that has attracted big investment but not yet secured approvals.   By Jason Mast STAT+ | China's WuXi AppTec, after evading threat of U.S. restrictions, comes out ahead Sales up 31.9% as Chinese contract research giant with extensive ties to American biopharma dodges national security effort to restrict its U.S. operations. By Brian Yang Federica Narancio/AP NIH funding cuts have affected over 74,000 people enrolled in experiments, a new report says Funding ceased for 383 studies that were testing treatments for conditions including cancer, heart disease, and brain disease. By Associated Press STAT+ | FDA clears spinal cord stimulator for home use Onward Medical announced Monday that it received regulatory clearance to expand the use of its spinal cord stimulator outside of clinics. By O. Rose Broderick Opinion: How emotions affect health care coverage decisions Recognizing how biases and emotions influence decisions is essential for navigating the impending changes in the health insurance landscape. By Amit Chandra and Alison Hoover Adobe STAT+ | Opinion: Sanofi CEO: How we're measuring AI success Paul Hudson, CEO of Sanofi, describes how his company is measuring return on investment for AI, or ROAI. By Paul Hudson STAT+ | Nuvalent sees success for its second genetically targeted lung cancer drug ALK+ lung cancer is a dramatic example of how targeting certain enzymes in tumors can produce dramatic results By Matthew Herper

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser